State-of-the-Art Management of Chronic Myeloid Leukemia in the Emerging Regions

被引:0
|
作者
Musteata, Vasile [1 ]
机构
[1] State Univ Med & Pharm N Testemitanu, Inst Oncol, Kishinev, Moldova
来源
关键词
CML; chronic myeloid leukemia; management; tyrosine kinase inhibitors; health equity;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CML-057
引用
收藏
页码:S286 / S286
页数:1
相关论文
共 50 条
  • [31] State-of-the-Art management of knee osteoarthritis
    Fibel, Kenton H.
    Hillstrom, Howard J.
    Halpern, Brian C.
    WORLD JOURNAL OF CLINICAL CASES, 2015, 3 (02) : 89 - 101
  • [32] Management of cardiogenic shock: state-of-the-art
    Jung, Christian
    Bruno, Raphael Romano
    Jumean, Marwan
    Price, Susanna
    Krychtiuk, Konstantin A.
    Ramanathan, Kollengode
    Dankiewicz, Josef
    French, John
    Delmas, Clement
    Mendoza, Alexandra-Arias
    Thiele, Holger
    Soussi, Sabri
    INTENSIVE CARE MEDICINE, 2024, 50 (11) : 1814 - 1829
  • [33] State-of-the-Art management of knee osteoarthritis
    Kenton H Fibel
    Howard J Hillstrom
    Brian C Halpern
    World Journal of Clinical Cases, 2015, (02) : 89 - 101
  • [34] State-of-the-art Management Accounting for SMEs
    Serap Demiröz
    Controlling & Management Review, 2019, 63 (8) : 56 - 61
  • [35] ATTR Amyloidosis: Current and Emerging Management Strategies JACC: CardioOncology State-of-the-Art Review
    Grif, Jan M.
    Rosenthal, Julie L.
    Grodin, Justin L.
    Maurer, Mathew S.
    Grogan, Martha
    Cheng, Richard K.
    JACC: CARDIOONCOLOGY, 2021, 3 (04): : 488 - 505
  • [37] URBAN SPEED MANAGEMENT, THE STATE-OF-THE-ART
    JORGENSEN, NO
    ACCIDENT ANALYSIS AND PREVENTION, 1992, 24 (01): : 1 - 2
  • [38] Resilience Engineering: A State-of-the-Art Survey of an Emerging Paradigm for Organisational Health and Safety Management
    Pillay, Manikam
    ADVANCES IN SAFETY MANAGEMENT AND HUMAN FACTORS, 2016, 491 : 211 - 222
  • [39] State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019
    Lemal, Richard
    Tournilhac, Olivier
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):